Ropes & Gray, Cooley Lead Lilly's $2.3B Cancer Drug Buy
Eli Lilly and Co. said Monday it will acquire privately held Ajax Therapeutics in a deal worth up to $2.3 billion, as the drugmaker looks to expand its pipeline of treatments...To view the full article, register now.
Already a subscriber? Click here to view full article